A platform allowing people to invest in the future earnings of individuals who have received life-extending gene therapies, in exchange for upfront funding for the treatment. This facilitates access for those who can't afford the treatment initially but are projected to benefit significantly. Addresses inequality but introduces potential exploitation risks.